[Treatment of tuberculosis resistant to 1st line drugs with rifampycin and ethambutol, twice a week, with an initial supplement of kanamycin].
D004352:Drug Resistance, Microbial; D004977:Ethambutol / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007612:Kanamycin / Q000008:administration & dosage*; D008297:Male; D012293:Rifampin / Q000008:administration & dosage*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D007612:Kanamycin; D004977:Ethambutol; D012293:Rifampin
Tratamiento de la tuberculosis resistente a las drogas de primera linea con rifampicina y ethambutol, dos veces por semana, con un suplemento inicial de kanamicina.